USD 0.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1000.00 USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | -100.0% |
2020 | 22.25 Thousand USD | 0.0% |
2019 | 22.25 Thousand USD | 0.0% |
2018 | 22.25 Thousand USD | 0.0% |
2017 | 22.25 Thousand USD | 0.0% |
2016 | 22.25 Thousand USD | 0.0% |
2015 | 22.25 Thousand USD | 20.86% |
2014 | 18.4 Thousand USD | 0.0% |
2013 | 18.4 Thousand USD | -14.77% |
2012 | 21.59 Thousand USD | -95.89% |
2011 | 526.04 Thousand USD | -45.69% |
2010 | 968.52 Thousand USD | -23.57% |
2009 | 1.26 Million USD | 5937.4% |
2008 | 20.99 Thousand USD | -95.71% |
2007 | 488.97 Thousand USD | 604.44% |
2006 | 69.41 Thousand USD | -67.25% |
2005 | 211.93 Thousand USD | 612.88% |
2004 | 29.73 Thousand USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 1000.00 USD | 0.0% |
2024 Q2 | 1000.00 USD | 0.0% |
2024 Q1 | 1000.00 USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | 1000.00 USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | 1000.00 USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2021 Q3 | 22.25 Thousand USD | 0.0% |
2021 Q4 | - USD | -100.0% |
2021 FY | - USD | -100.0% |
2021 Q1 | 22.25 Thousand USD | 0.0% |
2021 Q2 | 22.25 Thousand USD | 0.0% |
2020 Q4 | 22.25 Thousand USD | 0.0% |
2020 Q1 | 22.25 Thousand USD | 0.0% |
2020 Q2 | 22.25 Thousand USD | 0.0% |
2020 Q3 | 22.25 Thousand USD | 0.0% |
2020 FY | 22.25 Thousand USD | 0.0% |
2019 Q3 | 22.25 Thousand USD | 0.0% |
2019 FY | 22.25 Thousand USD | 0.0% |
2019 Q2 | 22.25 Thousand USD | 0.0% |
2019 Q4 | 22.25 Thousand USD | 0.0% |
2019 Q1 | 22.25 Thousand USD | 0.0% |
2018 Q4 | 22.25 Thousand USD | 0.0% |
2018 FY | 22.25 Thousand USD | 0.0% |
2018 Q3 | 22.25 Thousand USD | 0.0% |
2018 Q2 | 22.25 Thousand USD | 0.0% |
2018 Q1 | 22.25 Thousand USD | 0.0% |
2017 Q3 | 22.25 Thousand USD | 0.0% |
2017 Q1 | 22.25 Thousand USD | 0.0% |
2017 FY | 22.25 Thousand USD | 0.0% |
2017 Q4 | 22.25 Thousand USD | 0.0% |
2017 Q2 | 22.25 Thousand USD | 0.0% |
2016 Q1 | 22.25 Thousand USD | 0.0% |
2016 Q4 | 22.25 Thousand USD | 0.0% |
2016 Q3 | 22.25 Thousand USD | 0.0% |
2016 Q2 | 22.25 Thousand USD | 0.0% |
2016 FY | 22.25 Thousand USD | 0.0% |
2015 Q2 | 18.4 Thousand USD | 0.0% |
2015 Q1 | 18.4 Thousand USD | 0.0% |
2015 Q4 | 22.25 Thousand USD | 20.86% |
2015 FY | 22.25 Thousand USD | 20.86% |
2015 Q3 | 18.4 Thousand USD | 0.0% |
2014 Q1 | 18.4 Thousand USD | 0.0% |
2014 Q3 | 18.4 Thousand USD | 0.0% |
2014 Q4 | 18.4 Thousand USD | 0.0% |
2014 FY | 18.4 Thousand USD | 0.0% |
2014 Q2 | 18.4 Thousand USD | 0.0% |
2013 Q4 | 18.4 Thousand USD | -0.96% |
2013 FY | 18.4 Thousand USD | -14.77% |
2013 Q3 | 18.58 Thousand USD | -4.06% |
2013 Q2 | 19.37 Thousand USD | -5.43% |
2013 Q1 | 20.48 Thousand USD | -5.15% |
2012 Q1 | 524.93 Thousand USD | -0.21% |
2012 Q4 | 21.59 Thousand USD | -95.87% |
2012 FY | 21.59 Thousand USD | -95.89% |
2012 Q3 | 522.71 Thousand USD | -0.21% |
2012 Q2 | 523.82 Thousand USD | -0.21% |
2011 Q3 | 958.35 Thousand USD | -7.29% |
2011 Q4 | 526.04 Thousand USD | -45.11% |
2011 FY | 526.04 Thousand USD | -45.69% |
2011 Q1 | 986.77 Thousand USD | 1.88% |
2011 Q2 | 1.03 Million USD | 4.76% |
2010 Q1 | 1.18 Million USD | -6.25% |
2010 Q2 | 1.18 Million USD | -0.46% |
2010 Q4 | 968.52 Thousand USD | -63.47% |
2010 FY | 968.52 Thousand USD | -23.57% |
2010 Q3 | 2.65 Million USD | 124.17% |
2009 Q2 | 1.2 Million USD | -4.41% |
2009 Q4 | 1.26 Million USD | 9.09% |
2009 FY | 1.26 Million USD | 5937.4% |
2009 Q1 | 1.25 Million USD | 5890.3% |
2009 Q3 | 1.16 Million USD | -3.35% |
2008 Q2 | 99.76 Thousand USD | 0.0% |
2008 FY | 20.99 Thousand USD | -95.71% |
2008 Q1 | 99.76 Thousand USD | -79.6% |
2008 Q3 | 156.00 USD | -99.84% |
2008 Q4 | 20.99 Thousand USD | 13355.13% |
2007 Q4 | 488.97 Thousand USD | 291.2% |
2007 Q3 | 124.99 Thousand USD | 4.98% |
2007 Q2 | 119.06 Thousand USD | 756.72% |
2007 Q1 | 13.89 Thousand USD | -79.98% |
2007 FY | 488.97 Thousand USD | 604.44% |
2006 Q2 | 47.42 Thousand USD | -17.89% |
2006 Q1 | 57.75 Thousand USD | -72.75% |
2006 FY | 69.41 Thousand USD | -67.25% |
2006 Q4 | 69.41 Thousand USD | 20.46% |
2006 Q3 | 57.62 Thousand USD | 21.5% |
2005 Q4 | 211.93 Thousand USD | 293.32% |
2005 Q1 | 88.6 Thousand USD | 198.03% |
2005 Q3 | 53.88 Thousand USD | 27.05% |
2005 FY | 211.93 Thousand USD | 612.88% |
2005 Q2 | 42.41 Thousand USD | -52.13% |
2004 Q2 | - USD | 0.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | 29.73 Thousand USD | 0.0% |
2004 Q4 | 29.73 Thousand USD | 0.0% |
2004 Q1 | - USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
American Medical Technologies Inc. | 1.83 Million USD | 99.946% |
Ansell Limited | 3.23 Billion USD | 100.0% |
Ansell Limited | 3.24 Billion USD | 100.0% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 488.98 Million USD | 100.0% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | 300.36 Thousand USD | 99.667% |
Psykey, Inc. | 1.72 Million USD | 99.942% |
ConvaTec Group Plc | 3.7 Billion USD | 100.0% |
ConvaTec Group Plc | 3.71 Billion USD | 100.0% |
Encision Inc. | 3.81 Million USD | 99.974% |
Golden Valley Development, Inc | - USD | -Infinity% |
Hear AtLast Holdings, Inc. | - USD | -Infinity% |
Innovative MedTech Inc. | 651.88 Thousand USD | 99.847% |
LifePoint, Inc. | 8.8 Million USD | 99.989% |
Medite Cancer Diagnostics, Inc. | 15.95 Million USD | 99.994% |
Paradigm Medical Industries, Inc. | 895 Thousand USD | 99.888% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | 5.48 Million USD | 99.982% |
Reflect Scientific, Inc. | 2.66 Million USD | 99.963% |
SmileDirectClub, Inc. | 597.06 Million USD | 100.0% |
Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 100.0% |
SheerVision, Inc. | 837.56 Thousand USD | 99.881% |
United Health Products, Inc. | 284.64 Thousand USD | 99.649% |
Vasamed, Inc. | 1.6 Million USD | 99.938% |
Wearable Health Solutions, Inc. | 223.17 Thousand USD | 99.552% |
Yubo International Biotech Limited | 2.34 Million USD | 99.957% |